About Clinical Research
Clinical research is a branch of healthcare science that determines the safety and effectiveness of medications, devices, diagnostic products and treatment regimens intended for human use. These may be used for prevention, treatment, diagnosis or for relieving symptoms of a disease.
Hunt is on to find more effective flu treatments
......
Ukraine war: Cannabis in focus for veterans treatment
... " We have to do Clinical Research, to get more convincing evidence that it works, " he says, " because we really are the global epicentre of PTSD...
Puberty blockers to be given only in clinical research
...By Lauren Moss, LGBT correspondent & Josh Parry, LGBT producerBBC NewsPuberty blockers will only be prescribed to children attending gender identity services as part of Clinical Research, NHS England has announced...
Breast cancer gene linked to Orkney islands
... Analysis by Laura Goodwin, BBC Scotland Science and Innovation CorrespondentIdentifying this variant - BRCA1 V1736A - is the result of 25 years of Clinical Research by Prof Zosia Miedzybrodzka, the director of the NHS Grampian Clinical Genetics service...
China's new human gene-editing rules worry experts
... Many scientists have wondered how Dr He could be allowed to return to Clinical Research after prison...
Type 1 diabetes trial to identify at-risk children
... Parth Narendran, professor of diabetes medicine, and Dr Lauren Quinn, Clinical Research fellow at the University of Birmingham, said there was a need to explore if screening children for type 1 diabetes in the UK would be possible in the UK...
Google helps Newport woman discover rare heart condition
... Dr Alice Jackson, who is leading the study based in Scotland, is a Clinical Research fellow at the University of Glasgow s Institute of Cardiovascular and Medical Sciences...
Coronavirus: a Tiger at the Bronx Zoo tests positive for Covid-19
... Sarah Caddy, veterinary surgeon and Clinical Research Fellow at the University of Cambridge, react among the experts on the reports...
Type 1 diabetes trial to identify at-risk children
Researchers are recruiting 20,000 children for a trial to try to identify those at High Risk of developing type 1 diabetes.
If left undiagnosed or untreated, the condition can lead to life-threatening complications.
The Trial , led by the University of Birmingham, could mean access to new treatments for children at High Risk .
The researchers say it may also offer insights that could make screening for type 1 diabetes a possibility.
Type 1 diabetes is an autoimmune condition where the immune system attacks and destroys cells in the pancreas which produce insulin.
Insulin is crucial because it moves energy from food from The Blood to the cells of The Body - Without it, The Body cannot function properly.
Approximately 29,000 children in the UK currently have type 1 diabetes, out of a total of about 400,000 people. For them, managing the condition involves injecting insulin and testing Blood glucose levels regularly.
The condition is very different to type 2 diabetes, which is caused by poor diet or an unhealthy Lifestyle .
which will analyse their Blood - through finger prick and vein Tests - for autoantibodies.
These are linked to the development of type 1 diabetes. Those with two or more autoantibodies have an 85% chance of having the condition within 15 years, and are almost certain to develop it in their lifetime.
Parth Narendran, professor of diabetes medicine, and Dr Lauren Quinn, Clinical Research fellow at the University of Birmingham, Said there was a need to explore if screening children for type 1 diabetes in the UK would be possible in the UK.
" Screening children can reduce their risk of DKA (diabetic ketoacidosis) at diagnosis around fivefold and can help them and their families settle into The Type 1 diagnosis better, " they Said .
DKA is a life-threatening complication of type 1 which can occur when diagnosis does not happen quickly.
Rachel Connor, director of research partnerships at JDRF UK, which is co-funding the study, Said new drugs that target the immune system were progressing through trials.
" We Are demonstrating that it is possible to delay the need for intensive insulin treatment in those most At Risk . When these drugs become available in the UK, we need to be ready to use them straight away, " She Said .
Source of news: bbc.com
